Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    16983112 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: exatecan mesylate;   Drug: gemcitabine hydrochloride

Study has passed its completion date and status has not been verified in more than two years.